Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3425 of 3546 entries
View as:

Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox

Phase: N/A Priority: Normal
NCT ID: NCT00226499 Org: User:
Start: 09/01/05 End: 10/12/06 Due: 10/12/07

China Subpopulation: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT06868654 Org: User:
Start: 07/28/21 End: 06/19/26 Due: 06/19/27

A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01777282 Org: User:
Start: 02/23/13 End: 01/27/15 Due: 01/27/16

A Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine/Cervarix TM Vaccine in Healthy Females Aged 15-25 Years

Phase: N/A Priority: Normal
NCT ID: NCT00485732 Org: User:
Start: 06/11/07 End: 03/30/08 Due: 03/30/09

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Upper Limb Spasticity

Phase: N/A Priority: Normal
NCT ID: NCT01153815 Org: User:
Start: 04/30/10 End: 06/30/11 Due: 06/30/12

Bioequivalence (BE) Study of Test Griseofulvin 500 Milligram (mg) Tablets Versus Reference and Dose Proportionality Study of Test Griseofulvin 250 mg and 500 mg Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT04318535 Org: User:
Start: 01/13/20 End: 02/06/20 Due: 02/06/21

A Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Self-Administered Subcutaneously (SC) by Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01894360 Org: User:
Start: 10/14/13 End: 05/13/14 Due: 05/13/15

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Food Effect of Single or Repeat Doses of GSK2793660 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02058407 Org: User:
Start: 01/28/14 End: 10/31/14 Due: 10/31/15

A Single Dose Pharmacokinetics (PK) Study of GSK2434735 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01563042 Org: User:
Start: 02/13/12 End: 05/23/12 Due: 05/23/13

Outcomes Comparison of Chronic Immune Thrombocytopenic Purpura (ITP) Patients Switched to Eltrombopag and Romiplostim

Phase: N/A Priority: Normal
NCT ID: NCT01439321 Org: User:
Start: 11/30/10 End: 06/30/11 Due: 06/30/12

Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults

Phase: N/A Priority: Normal
NCT ID: NCT01323959 Org: User:
Start: 04/01/11 End: 03/01/12 Due: 03/01/13

A Single Dose Bioequivalence Study OfTwo Formulations Of Nicotine Lozenges

Phase: N/A Priority: Normal
NCT ID: NCT00651352 Org: User:
Start: 02/29/08 End: 03/31/08 Due: 03/31/09

A Study to Assess the Effects of GSK573719/VI Combination and GSK573719 Monotherapy in Subjects With Moderate Hepatic Impairment and Matched Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01577680 Org: User:
Start: 03/05/12 End: 06/29/12 Due: 06/29/13

Nebulized Fluticasone Propionate VS Oral Prednisone in Chinese Pediatric and Adolescent Subjects With an Acute Exacerbation of Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01687296 Org: User:
Start: 11/12/12 End: 06/21/13 Due: 06/21/14

Belimumab (BENLYSTA®) Pregnancy Registry

Phase: N/A Priority: Normal
NCT ID: NCT01532310 Org: User:
Start: 07/16/12 End: 11/11/22 Due: 11/11/23

A Tolerability Assessment Study of Three Wash Products in Infants

Phase: N/A Priority: Normal
NCT ID: NCT02403999 Org: User:
Start: 03/01/15 End: 04/27/15 Due: 04/27/16

An Open-label, Dose Escalation Study in Japanese Participants With Relapsed/Refractory Multiple Myeloma Who Have Failed Prior Anti Myeloma Treatments

Phase: N/A Priority: Normal
NCT ID: NCT03828292 Org: User:
Start: 03/14/19 End: 09/05/24 Due: 09/05/25

A Study on the Reactogenicity, Safety and Immune Response of a Vaccine Against Herpes Simplex Virus (HSV)-2 in Healthy Participants Aged 18-40 Years

Phase: N/A Priority: Normal
NCT ID: NCT04762511 Org: User:
Start: 03/02/21 End: 05/26/21 Due: 05/26/22

ARIXTRA Local Study For Registration In China.

Phase: N/A Priority: Normal
NCT ID: NCT00328939 Org: User:
Start: 05/31/04 End: - Due: -

A Study To Investigate The Effect Of Solabegron (GW427353) On Gastrointestinal Transit In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00401479 Org: User:
Start: 10/31/06 End: - Due: -

Pharmacokinetic Study of Topical GSK2894512 Cream

Phase: N/A Priority: Normal
NCT ID: NCT02466152 Org: User:
Start: 05/28/15 End: 10/27/15 Due: 10/27/16

Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Non Hodgkin's Lymphoma (NHL) Patients With Greater Than 25% Bone Marrow Involvement

Phase: N/A Priority: Normal
NCT ID: NCT00992758 Org: User:
Start: 05/28/99 End: 06/07/12 Due: 06/07/13

Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic Asthma

Phase: N/A Priority: Normal
NCT ID: NCT04276233 Org: User:
Start: 06/29/21 End: 10/28/23 Due: 10/28/24

Phase I Open-Label, Dose-Escalation Study of GSK1059615 in Patients With Solid Tumors or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00695448 Org: User:
Start: 06/24/08 End: 03/31/09 Due: 03/31/10

In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00354536 Org: User:
Start: 02/28/06 End: 09/30/06 Due: 09/30/07